Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Fostamatinib and Chronic Graft vs. Host Disease Development After Allogeneic Stem Cell Transplantation

NCT02611063 is registered in ClinicalTrials.gov with Stefanie Sarantopoulos, MD, PhD. as lead sponsor.

NCT NCT02611063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02611063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Fostamatinib and Chronic Graft vs. Host Disease Development After Allogeneic Stem Cell Transplantation
Lead sponsor
Stefanie Sarantopoulos, MD, PhD.
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2016
Completion date
February 22, 2022
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematological malignancies